WASHINGTON STATE CONVENTION CENTER

Seattle, Washington
March 4–7, 2019

 

Preliminary Agenda

The CROI Program and Information Guide, including all session and presentations, will be posted on CROI website 1 week prior to CROI.

Monday, March 4, 2019

9:00 AM - 1:30 PM

  • Program Committee Workshops for Young Investigators and Trainees
    Lunch for scholarship recipients will be served at 12:15 PM
    Conveners: John W. Mellors, University of Pittsburg, and Serena S. Spudich, Yale University

    Updates on HIV Virology
    Paul Bieniasz, The Rockefeller University

    Updates on HIV Immunology
    Penelope L. Moore, University of Witwatersrand

    Updates on HIV Prevention
    Sharon L. Hillier, University of Pittsburg

    Updates on Tuberculosis Treatment and Prevention
    Constance A. Benson, University of California San Diego

    Update on HIV Cure
    Katharine J. Bar, University of Pennsylvania

  • Martin Delaney Presentation, Doing It Better: Adolescents and HIV-Related Research

    Leaving Me Not Behind: My Experiences in Research

    Adolescent Development and HIV Control

    Ethics and Clinical Trials With Adolescents
    Kolawole S. Oyedeji, University of Lagos

2:00 PM - 4:00 PM

Concurrent Preconference Workshops

  • Frontiers in Laboratory Science Workshop
    Conveners: Galit Alter, Ragon Institute of MGH, MIT and Harvard, and Frank Kirchhoff, Ulm University Medical Center

    Engineering the Latent Reservoir
    Cannon Paula, University of Southern California

    Imaging the Whole Body Reservoir
    Jacob D. Estes, Oregon Health and Sciences University

    More Colors are Better
    Mario Roederer, Vaccine Research Center

  • Clinical Trial Design and Analysis Workshop
    Conveners: Susan P. Buchbinder, San Francisco Department of Public Health, and Richard E. Chaisson, The Johns Hopkins University

    Fellow Travelers: Interpreting the Impact of the Microbiome in Clinical Intervention
    Adam Burgener, Public Health Agency of Canada

    Missing U: Handling Missing Data in Clinical Trials
    Heather Ribaudo, Harvard University

    Designing and Interpreting Clinical Trials of HIV Prevention in the Era of Active Controls
    David Dunn, University College London

  • Interactive Case-Based Workshop on Hepatitis
    Conveners: Marion G. Peters, University of California San Francisco, and Andri Rauch, University Hospital Bern

    NASH in HIV
    Giada Sebastiani, McGill University Health Centre

    Retreatment of HCV in Advanced Liver Disease
    John D. Scott, University of Washington

    Hepatitis D: Clinical Challenges
    Jeffrey Glenn, Stanford University

    Hepatitis E: Clinical Challenges
    Sven Pischke, University Hospital Hamburg-Eppendorf

5:00 PM - 7:00 PM

Opening Session

  • Bernard Fields Lecture: Discovery and Development of HIV Broadly Neutralizing Antibodies
    Michel Nussenzweig, Rockefeller University

  • N’Galy-Mann Lecture: The Impact of Thailand's Achievements in HIV Treatment, Prevention, and Cure Research on Asia and the World
    Praphan Phanunphak, Thai Red Cross AIDS Research Centre

7:00 PM - 9:00 PM

Opening Reception

Tuesday, March 5, 2019

8:30 AM - 9:30 AM

Plenary Lectures

  • STIs: Apocalypse Now
    Jeanne M. Marrazzo, University of Alabama Birmingham

  • Inflammation: Taming the Flames
    Irini Sereti, NIAID, NIH
10:00 AM - 12:00 PM

Concurrent Oral Abstract Sessions

12:00 PM - 1:30 PM Lunch Break
1:30 PM - 2:30 PM

Concurrent Themed Discussions

2:30 PM - 4:00 PM Poster Abstract Sessions

4:00 PM - 6:00 PM

Concurrent Symposia

  • HIV-Associated Tumor Viruses: Partners in Crime
    Conveners: Thomas Schulz, Medizinischen Hochschule Hannover, and Jianxin You, University of Pennsylvania

    KSHV: Emerging Concepts in Oncogenesis and Immune Evasion
    Blossom Damania, University of North Carolina at Chapel Hill

    EBV: Immunopathogenesis and the Path to an EBV Vaccine
    Jeffrey Cohen, NIAID, NIH

    HPV: New Insights into Oncogenesis and Opportunities for Immune Control
    Denise Galloway, Fred Hutchinson Cancer Research Center

    HBV: From Viral Integration to Liver Cancer, New Targets and Approaches to Cure
    Fabien Zoulim, INSERM

  • ART and Reproduction
    Conveners: Meg Doherty, WHO, and Tendayi Westerhof, Pan African Positive Women's Coalition-Zimbabwe

    Update on Antiretrovirals and Birth Defects
    Lynne Mofenson, Elizabeth Glaser Pediatric AIDS Foundation Research Team

    ART Options and Treatment Decisions for Women of Reproductive Potential
    Monica Gandhi, University of California San Francisco

    Policy and Program Decisions for ART in Women of Reproductive Potential
    Irene Mukui, Ministry of Health

    Challenges in Antiretroviral Research in Women of Reproductive Potential
    Anne D. Lyerly, University of North Carolina at Chapel Hill

  • Adding Fuel to the Fire: Substance Use and HIV
    Conveners: Nabila El-Bassel, Columbia University, and Dianne Rausch, National Institute of Mental Health, Bethesda, MD, USA

    Chasing the Dragon: Opiates and HIV
    Ricky N. Bluthenthal, University of Southern California

    Chemsex and Implications for HIV Transmission and Management
    Mark Pakianathan, St George's Healthcare

    Hidden in Plain Sight: The Alcohol Epidemic
    Likeness C. Simbayi, Human Sciences Research Council

    Tobacco Smoking: The Silent Killer
    Lene Ryom, CHIP, Department of Infectious Diseases

Wednesday, March 6, 2019

8:00 AM - 9:30 AM

Plenary Lectures

  • Raising the Wall in Maternal/Fetal Immunity
    Sallie Permar, Duke University

  • Hugging Trees: Use of Phylogenetics for Public Health Intervention
    Alexandra M. Oster, CDC
10:00 AM - 12:00 PM

Concurrent Oral Abstract Sessions

12:00 PM - 1:30 PM Lunch Break
1:30 PM - 2:30 PM

Concurrent Themed Discussions

2:30 PM - 4:00 PM Poster Abstract Sessions

4:00 PM

Concurrent Symposia

  • Express Yourself: Provirus
    Conveners: Vicente Planelles, University of Utah School of Medicine, and Florence Margottin-Goguet, INSERM

    The Current Status of Latency Reversing Agents
    Carine Van Lint, Université Libre de Bruxelles

    Stochasticity: To Express or Not
    Leor Weinberger, Gladstone Institutes

    Role of the HUSH Complex in Viral Gene Expression
    Stephen P. Goff, Columbia University

    Effects of the HIV Provirus on Gene Expression
    Ya-Chi Ho, Yale School of Medicine

  • Coinfections: Tuberculosis, Hepatitis B and C, and HIV

    Dynamics of Acute HCV in Western Europe
    Jürgen K. Rockstroh, University of Bonn

    HCV Vaccine: Are We Getting There?
    Andrea Cox, The Johns Hopkins University

    Choices and Dilemmas: Preventing Tuberculosis in People with HIV Infection
    Amita Gupta, The Johns Hopkins University

    Treating Multidrug-Resistant Tuberculosis in the Real World: Impact of New Drugs and Shorter Course Regimens
    Jennifer Furin, Harvard Medical School

  • The Story of U: Implications of Undetectable Viral Load on Transmission
    Conveners: Eugene McCray, CDC, and Loice Achieng, University of Nairobi

    The History of U: Scientific Underpinnings
    Pietro L. Vernazza, Cantonal Hospital St Gallen

    Caring for U: Clinical Conundrums
    Nneka Nwokolo, Chelsea and Westminster Hospital

    Me and U: Community Perspectives
    Carrie Foote-Ardah, Indiana University

    Back to U: Unanswered Questions

    Andrew E. Grulich, University of New South Wales

Thursday, March 7, 2019

8:30 AM - 9:30 AM

Plenary Lectures

  • The Challenges of HIV Treatment in an Era of Polypharmacy
    David J. Back, University of Liverpool

  • Virology of NeuroHIV
    Ronald Swanstrom, University of North Carolina at Chapel Hill
10:00 AM - 12:00 PM

Concurrent Oral Abstract Sessions

12:00 PM - 1:30 PM Lunch Break
1:30 PM - 2:30 PM

Concurrent Themed Discussions

2:30 PM - 4:00 PM Poster Abstract Sessions

4:00 PM - 6:00 PM

Concurrent Symposia

  • New Cells on the Block
    Conveners: Caroline Tiemessen, National Institute of Communicable Diseases, and Johan Sandberg, Karolinska Institute

    Tissue-Resident Memory CD8+ Cells
    Michael R. Betts, University of Pennsylvania

    Innate Lymphoid Cells
    Jason Brenchley, NIAID, NIH

    Memory Natural Killer Cells
    Keith Reeves, Harvard Medical School

    Innate CD8+ Cell Function
    Deanna Kulpa, Emory University

  • Tough Questions in Antiretroviral Therapy Management
    Conveners: Jennifer Hoy, Alfred Hospital, and Georg Behrens, Medizinische Hochschule Hannover

    Obesity: A Growing Problem in Antiretroviral Therapy
    John R Koethe, Vanderbilt University Medical Center

    I Keep Forgetting: HIV, Aging, and Neurocognitive Disorder
    Victor Valcour, University of California San Francisco

    PrEP Failures: Diagnosis, Treatment, and Resistance
    Jean-Michel Molina, Hôpital Saint-Louis

    Can Two Drugs Tango: The Role of Dual Therapy
    Laura Waters, Mortimer Market Center

  • Girls and Boys Just Want to Have Fun: Making Prevention Desirable for Youth
    Conveners: Kame Shanaube, University of Zambia, and Kawango Agot, Impact Research and Development Organization

    Young Transgender Individuals
    Asa Radix, Callen-Lorde Community Health Center

    Engaging Young Women In Sub-Saharan Africa
    Sinead Delany-Moretlwe, Wits Reproductive Health and HIV Institute

    New Wave Approaches for Engaging Young MSM
    Lisa Hightow-Weidman, University of North Carolina at Chapel Hill

    Don't Leave Them Behind: Heterosexual Young Men
    Webster Mavhu, Centre for Sexual Health & HIV/AIDS Research